A marked reduction in tumor weight was associated with NK and anti‐NKG2A/Qa‐1b treatment when compared to treatments of control isotype, or single anti‐NKG2A/Qa‐1b mAbs or NK cells (Fig 3B). This evidence concerns the gene KLRC1 and neoplasm.